Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | IBI354 |
Trade Name | |
Synonyms | IBI-354|IBI 354 |
Drug Descriptions |
IBI354 is an antibody-drug conjugate (ADC) comprising an ERBB2 (HER2)-targeting monoclonal antibody linked to a camptothecin derivative, which potentially induces cell cycle arrest and apoptosis in Erbb2 (Her2)-expressing tumor cells (NCI Drug Dictionary). |
DrugClasses | HER2 (ERBB2) Antibody-Drug Conjugate 29 |
CAS Registry Number | NA |
NCIT ID | C198994 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IBI354 | IBI354 | 0 | 1 |